- Report
- October 2024
- 195 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- November 2023
- 30 Pages
Global
From €2503EUR$2,750USD£2,146GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €455EUR$500USD£390GBP
Temodar is a brand name for temozolomide, a chemotherapy drug used to treat certain types of skin cancer. It is a type of alkylating agent, which works by interfering with the growth of cancer cells. Temodar is used to treat melanoma, a type of skin cancer that can spread to other parts of the body. It is also used to treat basal cell carcinoma, a type of skin cancer that is usually localized to the skin. Temodar is typically administered orally, and is available in both capsule and oral suspension forms.
Temodar is marketed by Merck & Co., Inc., and is available in the United States, Canada, and Europe. It is also available in some other countries, including Australia, New Zealand, and South Africa. Other companies that market temozolomide include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more